baber/WOPTO huggingface dataset:
Patent FI-842512-A0 (FI)
Inventor: FABIAN PETER
IPC: C25B11/00
Filed: 1984-06-20
Abstract: PCT No. PCT/EP83/00265 Sec. 371 Date Jun. 21, 1984 Sec. 102(e) Date Jun. 21, 1984 PCT Filed Oct. 8, 1983 PCT Pub. No. WO84/01789 PCT Pub. Date May 10, 1984.A bipolar electrode has plate-like anode and cathode parts. The anode and cathode parts are secured together, edge-to-edge, to form a single element in one plane by an intermediate connecting piece. The intermediate connecting piece itself is a composite element having parts of materials which are compatible with the respectively adjacent anode and cathode. The two parts of the composite element are joined together by hot isostatic pressure, explosion-plating or diffusion-welding into the composite body, the resultant composite body then permitting welding of the respective anode and cathode plates to the respective anode part and cathode part of the composite element or body.
Patent FI-851474-A0 (FI)
Inventor: WEIL WOLFGANG HERMAN
IPC: B23K11/30
Filed: 1985-04-12
Abstract: The copper wires employed for electrical resistance seam welding of tinned sheet metal with the help of wire electrodes until now had to be taken back to the smelter as old metal after a few applications. The additional operating costs associated with this were until now unavoidable for long seam resistance welding of tinned sheet metal since multiple uses or applications of the copper wire for resistance seam welding have proven to be impossible in spite of years of research. The problem of these additional operating costs can be solved such that new copper wires with a reduced diameter can be directly drawn from the copper wire employed as wire electrodes for resistance seam welding after their use in welding. These wires then, for example, can be used as signal conductors or as windings. The properties of these wires are totally in accord with copper wires that are directly drawn from new copper. By this process, the additional operating costs mentioned above are substantially reduced and in many cases are even totally eliminated.
Patent FI-870928-A0 (FI)
Inventor: VAN BROEKHOVEN JOHANNES ADRIAN
IPC: B01J31/18
Filed: 1987-03-03
Abstract: Novel catalyst compositions, characterized in that they are based upon 
 
  a) a palladium compound, 
  b) a non-noble transition metal salt of an acid with a pKa of less than 2, provided that the acid is not a hydrohalogenic acid, or a mixture of such a salt and such an acid, 
  c) a bidentate ligand of the general formula R<1>R<2>-M-R-M-R<3>R<4>, wherein M represents phosphorus, arsenic or antimony, R<1>, R<2>, R<3> and R<4> represent hydrocarbyl groups which may or may not be substituted with polar groups and R represents a bivalent organic bridging group having at least two carbon atoms in the bridge, and 
  d) a quinone, if desired.
Patent FI-871184-A0 (FI)
Inventor: ZIEMEK GERHARD
IPC: D07B3/04
Filed: 1987-03-18
Abstract: In a device for the stranding or stranding-on of stranding elements to form a cable, stranding members of a stranding machine and storage receivers of the machine are combined to form a unit, and are present in duplicate to be interchangeable with each other. The unit with the storage receiver which has just been filled forms the active part and the other unit with the storage receiver which is to be filled forms the passive part in a stranding operation.
Patent FI-880464-A0 (FI)
Inventor: NEESER JEAN-RICHARD
IPC: A23G3/36
Filed: 1988-02-02
Abstract: Agents inhibiting adhesion of the bacteria responsible for the formation of dental plaque and dental caries are isolated from kappa-caseinoglycopeptides of bovine, caprine or ovine origin. 
<??>These agents are shown to be very active in experimental systems in which traditional inhibitors such as lactose and galactose prove ineffective, as well as in experiments in which no inhibitors are known.
Patent FI-883454-A0 (FI)
Inventor: WESS GUENTHER
IPC: C07C323/00
Filed: 1988-07-21
Abstract: Leukotriene antagonists, a process for the preparation thereof, and the use thereof for the treatment of diseases    <IMAGE>  (I)  in which R1, R2, R3, R4, R5 and X have the indicated meanings, a process for the preparation of these compounds, the use thereof as pharmaceuticals, and pharmaceutical products based on these compounds, are described.
Patent FI-902484-A0 (FI)
Inventor: TUOMISTO MAUNO
IPC: E06B3/26
Filed: 1990-05-21
Abstract: The invention relates to a window comprising a casing (1) and one or more frames (2a, 2b, 2c) fastened to said casing and carrying the glazing panes (3) and in which the opposing faces of the frames and the surrounding casing are at an oblique angle with respect to the plane of the glazing. In the window built according to this invention, the cross-sectional sides (4a, 4b, 4c, 4d) of the frame (2) form a square or a lozenge-shaped quadrangle located at an oblique angle with respect to the glazing plane and symmetrically around the whole glazing, the frame sections having four mainly similar faces which may be located at alternate positions with respect to the casing or a neighbouring frame. This kind of window offers a number of functional, technical, and applicational advantages in comparison with the window types currently in use.
Patent FI-911712-A0 (FI)
Inventor: DAIRE ERICK
IPC: C08F4/60
Filed: 1991-04-10
Abstract: The present invention relates to an alpha-olefin prepolymer catalytically active in an alpha-olefin (co-)polymerization comprising a transition metal, an organometallic compound and an antistatic agent. The prepolymer can be prepared by contacting the antistatic agent with a catalyst comprising the transition metal and the organometallic compound before or during an alpha-olefin prepolymerization. It can also be prepared by contacting the antistatic agent with an alpha-olefin prepolymer after a prepolymerization. It can also be prepared by a combination of the two methods. The prepolymer can be introduced into a gas phase (co-)polymerization medium for preparing polyolefin directly in a dry powder form, with a reduced amount of sheeting and agglomerates.
Patent FI-912291-A0 (FI)
Inventor: ADDOR ROGER WILLIAMS
IPC: A01P7/04
Filed: 1991-05-10
Abstract: This invention provides new N-acylated arylpyrroles of formula (I)   <CHEM> effective for the control of insects, acarids, nematodes, fungi and mollusks and useful for the protection of growing plants from the destructive actions of said pests. The invention also provides pesticidal compositions containing the new N-acylated arylpyrroles and methods for the preparation of thereof.
Patent FI-920636-A0 (FI)
Inventor: PICKEN ROGER N
IPC: C12Q1/68
Filed: 1992-02-14
Abstract: Nucleic acid primers of complementary sequence to portions of the gene encoding a semiconserved region of B. burgdorferi flagellin are utilized to amplify target sequences of nucleic acids extracted from infective sites of Lyme borreliosis, which are then probed with a nucleic acid tracer conjugated to signal-generating molecules for highly specific detection of B. burgdorferi.
Patent FI-921364-A0 (FI)
Inventor: GLEIM GUNTER
IPC: G11B7/085
Filed: 1992-03-27
Abstract: A direction-determination logic is used in compact-disc players to establish in which direction the scanner is travelling across the tracks of the disc after either an intentional jump or an unintentional one caused by a knock, for instance. In order to determine in which direction the scanning light beam is travelling across the disc tracks, the phase difference between a track error signal (TE) and the envelope of the HF signal (HF) which generates the scanning light beam is only evaluated if the speed with which the light beam travels across the tracks is below a given value. The logic of the invention for the determination of the direction of motion of the scanner can be used in compact-disc players, video-disc players, DRAW-disc players and magneto-optical instruments.
Patent FI-925503-A0 (FI)
Inventor: LOUKUSA JARMO
IPC: G06F11/267
Filed: 1992-12-03
Abstract: The invention relates to a method of and a system for checking the operation of a microprocessor. According to the invention, functions performing desired tests are included in the software of the microprocessor (1), microprocessor status data produced by the tests are written successively to a data bus (3) of the microprocessor, the successive status data are read from the data bus (3), each to a separate register (7a to 7n), the status data and the results of the tests are presented in parallel at outputs (a to n) of the registers (7a to 7n).
Patent FI-932209-A0 (FI)
Inventor: BRUN CLAUDE
IPC: C08F4/60
Filed: 1993-05-14
Abstract: Porous MgCl2 particles existing, under the microscope, in the form of substantially regular polyhedra having ten to eighteen faces. These particles, impregnated with transition metal compound, are used as catalytic component in the polymerisation of olefins.
Patent FI-940074-A0 (FI)
Inventor: BASTART JEAN-PIERRE
IPC: A61K47/44
Filed: 1994-01-07
Abstract: The invention relates to new compositions based on derivatives of the taxane class, consisting of solutions of these derivatives in a solvent mixture composed of ethanol and polysorbate. These solutions are used to prepare perfusions.
Patent FI-945411-A0 (FI)
Inventor: FURMAN DEANNA KIMBERLY
IPC: A23L27/20
Filed: 1994-11-17
Abstract: The present invention relates to coolant compositions comprising a ketal and a secondary coolant which may be menthol, carboxamides or mixtures thereof.
Patent IL-86288-A0 (IL)
Title: Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
IPC: A61K31/43
Filed: 1988-05-05
Abstract: Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(1S-oxo-3R-thiolanylthio )-2-penem-3-carboxylic acid and 5R,6S-6-(1R-hydroxyethyl)-2-(1R-oxo-3S-thiolanylthio )-2-penem-3-carboxylic acid, and pharmaceutically-acceptable salts and in vivo hydrolyzable esters thereof, useful as systemic antibacterial agents; and intermediates and processes which are useful in the said synthesis of said diastereoisomers.
Patent IL-87036-A0 (IL)
Title: 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic acids,7-(1h-pyrrol-3-yl)substituted 3,5-dihydroxyheptanoic acids,their corresponding delta-lactones and salts,processes for their preparation and pharmaceutical compositions
IPC: A61P3/06
Filed: 1988-07-08
Abstract: 7-[1H-Pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids and 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyheptanoic acids of the formula I 
<IMAGE>
 in which A, B, R<1>, R<2>, R<3>, R<4> and R<5> have the meanings given, and the corresponding  delta -lactones of the formula II 
<IMAGE>
 are described.
Patent FI-20021038-A0 (FI)
Inventor: JAERVENTIE JUSSI
IPC: C05D3/02
Filed: 2002-05-31
Abstract: A process for treating organic material, separating calcium and recovering phosphorus and to utilization of the obtained products and their use as a soil conditioner and a fertilizer as well as for providing carbon dioxide traps in gas cleaning. In the process, organic ingredients are separated from calcium-phosphate-containing ingredients, the calcium-phosphate-containing ingredients are dissolved in an acid-containing solution and/or the calcium is precipitated as a salt corresponding to the acid, and optionally phosphoric acid formed from a phosphate ion is separated. The invention also relates to a calcium-carbonate-containing product and a phosphoric-acid containing product, which are prepared by the process of the invention.
Patent IL-101600-A0 (IL)
Title: Synthetic antisense deoxyoligonucleotides and pharmaceutical compositions containing the same
IPC: A61P35/00
Filed: 1992-04-15
Abstract: PCT No. PCT/EP93/00911 Sec. 371 Date Dec. 1, 1994 Sec. 102(e) Date Dec. 1, 1994 PCT Filed Apr. 15, 1993 PCT Pub. No. WO93/21202 PCT Pub. Date Oct. 26, 1993The invention relates to synthetic phosphorothioated or partially phosphorothioated oligodeoxynucleotides capable of selectively modulating hemopoietic bone marrow cells development. More particularly, the invention relates to synthetic antisense oligodeoxynucleotides directed against a region spanning the AUG initiation condon in human ACHE or 2HS genes, having phosphorothioate bonds linking between the nucleotide bases; synthetic antisense oligodeoxynucleotides directed against a region spanning the AUG initiation condon in human ACHE gene, 2HS gene or BCHE gene or against a 5'-region in the human CHED (cdc2 homolog) gene, having phosphorothioate bonds linking between the four 3'-terminus nucleotide bases. The invention also relates to pharmaceutical compositions comprising as active ingredient at least one synthetic phosphorothioated or partially phosphorothioated antisense oligodeoxynucleotides according to the invention in physiologically acceptable carrier in diluent. The antisense oligodeoxynucleotides of the invention and the pharmaceutical compositions containing them are suitable for inhibiting abnormal hemopoietic cells proliferation, inhibiting abnormal platelet proliferation, increasing stem cell fraction in bone marrow cell cultures, enhancing macrophage production and increasing stem cells counts, reducing immune response of organs to be transplanted, suppressing immune response of a recipient of an allotransplanted organ, and arresting growth of malignant tumors.
Patent IL-102032-A0 (IL)
Title: 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
IPC: A61P9/00
Filed: 1992-05-28
Abstract: The present invention relates to new 2-amino-5-cyano-4-quinoline-1,4-dihydropyridines, processes for their preparation and their use in medicaments, in particular in agents for the treatment of cardiovascular diseases.
Patent IL-105727-A0 (IL)
Title: Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase
IPC: A61K31/55
Filed: 1993-05-18
Abstract: The present invention relates to novel mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
Patent IL-106550-A0 (IL)
Title: Rotating induction electrical generator
IPC: H02P9/48
Filed: 1993-08-02
Abstract: A rotary induction generator having a stator with stator windings (21) defining a three-phase stator and a rotor mounted for rotation therein and having wound thereon three rotor windings (22) defining a three-phase rotor and having resistive-reactive means (23, 24, 26) connected to said secondary windings (22) to increase the efficiency of said generator and limit the power output to the capacity of the generator over a wide range of speeds; and the method for load limiting electric power generation with rotary induction generators wherein the generator can run at variable speeds while maintaining the frequency of the line connected thereto over a wide range of prime mover speeds whereby the excess kilowatt output is limited by the circuit employing a first circuit of three sets of resistance, inductance and capacitance means (23, 24, 26) connected in series from each leg of a wye or delta configuration, and wherein each of said sets is connected in parallel with a separate set of resistors (27) to complete the circuit therein and assist in controlling the maximum point in kilowatts.
Patent IL-128670-A0 (IL)
Title: Method to obtain oestrogens from mares' urine
IPC: A61K31/566
Filed: 1996-08-30
Abstract: Disclosed is a method to obtain an extract containing a natural mixture of conjugated oestrogens from mare's urine by solid-phase extraction of the mixture of conjugated oestrogens from pregnant mare's urine on non-ionic semipolar polymer adsorbing resins.
Patent IL-148602-A0 (IL)
Title: Image-recording device for a printing form, having an array of vcsel light sources
IPC: B41J2/45
Filed: 2002-03-10
Abstract: Arrangement for illustrating a printing forme (16) has an array (10) of light sources (12) and imaging optics (14) for generation of a matrix of image points on the printing forme. The light sources are vertical cavity surface emitting laser (VCSEL) light sources that can be independently controlled. The invention also relates to a corresponding printing forme illuminator and a printing machine.
Patent IL-156448-A0 (IL)
Title: Sytem and method for pre-programming an electronic device's memory
IPC: H04W88/02
Filed: 2001-12-13
Abstract: A system and method for parallel programming an electronic device's memory during manufacturing. In one embodiment, the electronic device is programmed in parallel with test code and a portion of the system code prior to board level testing. The test code is then used during board level testing of the electronic device. Once board level testing is complete, the electronic device is programmed with additional system code to complement the existing system code, whereby system level testing is then performed.
Patent IL-160480-A0 (IL)
Title: Robotic endoscope with wireless interface
IPC: G02B23/24
Filed: 2003-06-19
Abstract: An endoscope apparatus and method of operating the same. The endoscope apparatus comprises an endoscope portion and a control and display unit. The endoscope portion preferably comprises: (i) a sensor disposed at a distal end of the endoscope portion and providing endoscope data; (ii) one or more electronically controlled actuators (e.g., electroactive polymer actuators) controlling the operation of the endoscope portion based on received control signals; (iii) a first wireless transceiver coupled to the sensor and the one or more electronically controlled actuators, transmitting received endoscope data from the sensor and forwarding received control signals to the one or more electronically controlled actuators; and (iv) a portable power source (e.g., a battery) coupled to the sensor, the first wireless transceiver, and the one or more electronically controller actuators. The control and display unit preferably comprises: (i) a second wireless transceiver coupled via a wireless link to the first transceiver in the endoscope portion and receiving endoscope data from the first transceiver and transmitting control signals to the first transceiver; (ii) a control portion coupled to the second wireless transceiver and sending control signals to the one or more actuators in the endoscope portion via the first and second wireless transceivers; and (iii) a display portion that displays information received from the sensor via the first and second wireless transceivers. Another aspect of the present invention is directed to a method for providing single-use endoscopes to one or more hospitals.
Patent IL-162006-A0 (IL)
Title: Secure offline interactive gambling
IPC: G07F17/32
Filed: 2002-12-27
Abstract: A secure offline interactive gambling system (10) includes a subscriber unit (30) operative, through interaction with a user, to execute an offline interactive gambling application, a secure processor (140) operatively associated with the subscriber unit (30) and a central gambling facility. The secure processor (140) includes a secure memory (200) operatively operative to securely store information related to the execution of the offline interactive gambling application. The information, that is securely stored and the user cannot modify, typically includes the gambling input and user selections made in response to gambling input and can be used to derive at least one result of the offline interactive gambling application. The information is transmitted to the central gambling facility that re-executes the offline interactive gambling application with the information replacing the gambling input actually generated and the user selections actually entered. By re-executing the offline interactive gambling application at the central gambling facility the at least one result is derived and validated and the user may be credited or debited based on the at least one result. Related apparatus and method are also described.
Patent IL-177453-A0 (IL)
Title: Detection of skin impedance
Filed: 2006-08-10
Abstract: Apparatus and methods are provided for determining in near realtime the position of a probe placed within a living body. Electric currents are driven between one or more electrodes on the probe and electrodes placed on the body surface. The impedance between the probe and each of the body surface electrodes is measured, and three-dimensional position coordinates of the probe are determined based on the impedance measurements. Dynamic compensation is provided for changing impedance of the body surface and its interface with the electrodes, resulting from such causes as electrode peel-off and changes in moisture and temperature. The compensation improves the accuracy of,  inter alia,  medical procedures, such as mapping the heart or performing ablation to treat cardiac arrhythmias.
Patent IL-182362-A0 (IL)
Title: Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin
Filed: 2007-04-01
Abstract: This invention relates to the use in the treatment of HCV infection, either as single active agents or in combination with another active agent, of a cyclosporin having increased cyclophilin binding activity and essentially lacking immunosuppressive activity.
Patent IL-202617-A0 (IL)
Title: Pyrimidyl cyclopentanes as akt protein kinase inhibitors
Filed: 2009-12-09
Abstract: The present invention provides compounds of Formula  I , including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.     Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Patent RO-131972-A0 (RO)
Title: Process and plant for biogas production
Inventor: ŞTEFAN DANIELA SIMINA
IPC: C02F11/04
Filed: 2017-02-15
Abstract: The invention relates to a process for preparing biogas by anaerobic fermentation of biodegradable wastes and to a plant for carrying out the process. According to the invention, the process comprises the anaerobic fermentation of biodegradable wastes in suspension, at a humidity of 85...95%, at an optimal temperature for each stage, i.e. in the range of 25...35°C for hydrolysis and acidogenesis and in the range of 30...60°C for acetogenesis and methanogenesis, the retention time ranging between 10...50 days, the C:N ratio ranging between 15...45, the optimal pH value being in the range of 5.0...6.5 for hydrolysis and acidogenesis and in the range of 6.0...7.5 for acetogenesis and methanogenesis, the resulting biogas being purified by desulphurization, to obtain biogas with a methane content of 55...75%. The plant for carrying out the process comprises an installation (1.1) for chopping, dosing and transporting plant wastes, optionally provided for the case in which plant wastes are used, a system (1.2) for distribution and dosage of other starting materials, animal dejections, food wastes, sludge from purification plants, a longitudinal parallelepipedal bioreactor (2) having a plurality of compartments and being provided with baffle plates, a stirrer (3) placed in a first compartment (2) for homogenizing the starting material, a biogas barbotage homogenization system (4), using a blower (5), for a compartment (2), a heating system (6) having the possibility of adjusting the temperature for each compartment, an acid/base dosing system (7) for pH adjustment, i.e. acid/calcium hydroxide, a centrifugal decanter (11), a sludge storing platform (13), a gasometer (15) for biogas storage, a desulphurization unit (17) and a co-generation unit (18).